Edition:
India

Tenax Therapeutics Inc (TENX.OQ)

TENX.OQ on NASDAQ Stock Exchange Capital Market

0.45USD
8:41pm IST
Change (% chg)

$0.02 (+3.51%)
Prev Close
$0.43
Open
$0.43
Day's High
$0.45
Day's Low
$0.43
Volume
32,097
Avg. Vol
70,953
52-wk High
$2.64
52-wk Low
$0.31

Chart for

About

Tenax Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing products for the critical care market. The Company's main product is levosimendan. Levosimendan is a calcium sensitizer developed for intravenous use in hospitalized patients with acutely... (more)
No analyst recommendations are available for .

Overall

Beta: 1.92
Market Cap(Mil.): $14.39
Shares Outstanding(Mil.): 28.24
Dividend: --
Yield (%): --

Financials

BRIEF-Tenax Therapeutics says company's board is continuing its review of strategic alternatives

* Tenax Therapeutics provides regulatory update on Levosimendan

29 Jul 2017

BRIEF-Asterias Biotherapeutics completes enrollment and dosing of a cohort of an early-stage study

* Asterias Biotherapeutics completes enrollment and dosing of scistar study's ais-a 20 million cell cohort

17 Jul 2017

Competitors

  Price Chg
Novartis AG (NOVN.S) CHF83.95 +0.15
Merck & Co., Inc. (MRK.N) $56.42 +0.18
Roche Holding Ltd. (ROG.S) CHF246.60 +2.50
Roche Holding Ltd. (RO.S) CHF246.90 +3.50
Abbott Laboratories (ABT.N) $56.00 +0.50
Bayer AG (BAYGn.DE) €108.30 +1.80
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €74.45 +0.90
Eli Lilly and Co (LLY.N) $86.55 +0.01
Bristol-Myers Squibb Co (BMY.N) $62.45 +0.04

Earnings vs. Estimates